COVID-19 in Africa: care and protection for frontline healthcare workers
MF Chersich, G Gray, L Fairlie, Q Eichbaum… - Globalization and …, 2020 - Springer
Medical staff caring for COVID-19 patients face mental stress, physical exhaustion, separation
from families, stigma, and the pain of losing patients and colleagues. Many of them have …
from families, stigma, and the pain of losing patients and colleagues. Many of them have …
Effectiveness of BNT162b2 vaccine against omicron variant in South Africa
…, H Moultrie, LG Bekker, G Gray - New England Journal …, 2022 - Mass Medical Soc
Preliminary Data on Vaccine Protection against Omicron Using a test-negative study design
focused on the period of dominance of the B.1.1.529 (omicron) variant in South Africa, …
focused on the period of dominance of the B.1.1.529 (omicron) variant in South Africa, …
Gender-based violence, relationship power, and risk of HIV infection in women attending antenatal clinics in South Africa
Background Gender-based violence and gender inequality are increasingly cited as
important determinants of women's HIV risk; yet empirical research on possible connections …
important determinants of women's HIV risk; yet empirical research on possible connections …
Safety and efficacy of the HVTN 503/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept …
GE Gray, M Allen, Z Moodie, G Churchyard… - The Lancet infectious …, 2011 - thelancet.com
Background The MRKAd5 HIV-1 gag/pol/nef subtype B vaccine was designed to elicit T-cell-mediated
immune responses capable of providing complete or partial protection from HIV-1 …
immune responses capable of providing complete or partial protection from HIV-1 …
Effectiveness of the Ad26. COV2. S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B …
…, J Odhiambo, F Mayat, S Takuva, L Corey, GE Gray… - The Lancet, 2022 - thelancet.com
Background We aimed to assess the effectiveness of a single dose of the Ad26.COV2.S
vaccine (Johnson & Johnson) in health-care workers in South Africa during two waves of the …
vaccine (Johnson & Johnson) in health-care workers in South Africa during two waves of the …
[HTML][HTML] Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2
…, E Were, KH Fife, G de Bruyn, GE Gray… - New England journal …, 2010 - Mass Medical Soc
Background Most persons who are infected with human immunodeficiency virus type 1 (HIV-1)
are also infected with herpes simplex virus type 2 (HSV-2), which is frequently reactivated …
are also infected with herpes simplex virus type 2 (HSV-2), which is frequently reactivated …
Tracking the circulating SARS-CoV-2 variant of concern in South Africa using wastewater-based epidemiology
…, N Mahlangeni, C Webster, M Mdhluli, G Gray… - Scientific Reports, 2022 - nature.com
This study uses wastewater-based epidemiology (WBE) to rapidly and, through targeted
surveillance, track the geographical distribution of SARS-CoV-2 variants of concern (Alpha, …
surveillance, track the geographical distribution of SARS-CoV-2 variants of concern (Alpha, …
Safety and efficacy of single-dose Ad26. COV2. S vaccine against Covid-19
J Sadoff, G Gray, A Vandebosch… - … England Journal of …, 2021 - Mass Medical Soc
Background The Ad26.COV2.S vaccine is a recombinant, replication-incompetent human
adenovirus type 26 vector encoding full-length severe acute respiratory syndrome coronavirus …
adenovirus type 26 vector encoding full-length severe acute respiratory syndrome coronavirus …
T cell responses to SARS-CoV-2 spike cross-recognize Omicron
The SARS-CoV-2 Omicron variant (B.1.1.529) has multiple spike protein mutations 1 , 2 that
contribute to viral escape from antibody neutralization 3 , 4 , 5 – 6 and reduce vaccine …
contribute to viral escape from antibody neutralization 3 , 4 , 5 – 6 and reduce vaccine …
Vaccine efficacy of ALVAC-HIV and bivalent subtype C gp120–MF59 in adults
GE Gray, LG Bekker, F Laher… - … England Journal of …, 2021 - Mass Medical Soc
Background A safe, effective vaccine is essential to eradicating human immunodeficiency
virus (HIV) infection. A canarypox–protein HIV vaccine regimen (ALVAC-HIV plus AIDSVAX B/…
virus (HIV) infection. A canarypox–protein HIV vaccine regimen (ALVAC-HIV plus AIDSVAX B/…
